PresentationOperator Ladies and gentlemen, thank you for standing by. At this time, I would like to welcome everyone to Skye Biosciences conference call to discuss Phase IIa top line clinical trial results. I would now like to turn the conference over to Bernie Hertel, Head of Investor Relations. Please go ahead. ...